PURE Bioscience, Inc. (PURE)
USD 0.06
(-14.29%)
USD 0.06
(-14.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.53 Million | -3.27 Million | -2.41 Million | -1.16 Million | 669 Thousand | -2.99 Million |
| Net Income | -3.35 Million | -3.96 Million | -3.49 Million | -2.31 Million | 4000.00 | -6.55 Million |
| Depreciation & Amortization | 148 Thousand | 117 Thousand | 213 Thousand | 172 Thousand | 192 Thousand | 241 Thousand |
| Deferred income taxes | - | 107 Thousand | - | - | - | 960 Thousand |
| Stock-based compensation | 214 Thousand | 324 Thousand | 567 Thousand | 841 Thousand | 787 Thousand | 2.44 Million |
| Change in working capital | 397 Thousand | -107 Thousand | 103 Thousand | -11 Thousand | -318 Thousand | -125 Thousand |
| Other non-cash items | 60 Thousand | 242 Thousand | 190 Thousand | 150 Thousand | 4000.00 | 39 Thousand |
| Investing Cash Flow | - | -33 Thousand | -81 Thousand | -521 Thousand | -58 Thousand | -13 Thousand |
| Investments in PPE | - | -33 Thousand | -81 Thousand | -521 Thousand | -58 Thousand | -13 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -6000.00 |
| Financing Cash Flow | 1.78 Million | 1.01 Million | 3.5 Million | 239 Thousand | 2.83 Million | 2.55 Million |
| Debt repayment | -1.78 Million | -1.01 Million | - | -239 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 3.5 Million | - | 2.83 Million | 1.71 Million |
| Other Financing Activities | 1.78 Billion | 1.01 Million | 3.5 Million | 239 Thousand | 2.83 Million | 840 Thousand |
| Accounts receivables | -13 Thousand | -84 Thousand | 167 Thousand | 721 Thousand | -716 Thousand | -98 Thousand |
| Accounts payables | 201 Thousand | -43 Thousand | -156 Thousand | -781 Thousand | 772 Thousand | -38 Thousand |
| Inventory | 32 Thousand | 57 Thousand | 78 Thousand | 65 Thousand | -370 Thousand | 20 Thousand |
| Other working capital | 177 Thousand | -37 Thousand | 14 Thousand | -16 Thousand | -4000.00 | -9000.00 |
| Cash at beginning of period | 1.17 Million | 3.46 Million | 2.46 Million | 3.91 Million | 473 Thousand | 926 Thousand |
| Cash at end of period | 424 Thousand | 1.17 Million | 3.46 Million | 2.46 Million | 3.91 Million | 473 Thousand |
| Capital Expenditure | - | -33 Thousand | -81 Thousand | -521 Thousand | -58 Thousand | -13 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -746 Thousand | -2.29 Million | 1 Million | -1.44 Million | 3.44 Million | -453 Thousand |
| Free Cash Flow | -2.53 Million | -3.31 Million | -2.49 Million | -1.68 Million | 611 Thousand | -3 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -756 Thousand | -857 Thousand | -1 Million | -735 Thousand | -3.96 Million | -1.03 Million |
| Depreciation & Amortization | 38 Thousand | 36 Thousand | 37 Thousand | 37 Thousand | 117 Thousand | 15 Thousand |
| Deferred income taxes | - | - | -193 Thousand | -196 Thousand | 107 Thousand | - |
| Stock-based compensation | 38 Thousand | 32 Thousand | 64 Thousand | 80 Thousand | 324 Thousand | 49 Thousand |
| Change in working capital | 87 Thousand | 114 Thousand | 18 Thousand | 178 Thousand | -107 Thousand | -85 Thousand |
| Other non-cash items | 38 Thousand | 106 Thousand | 193 Thousand | 196 Thousand | 242 Thousand | 309 Thousand |
| Investing Cash Flow | - | - | - | - | -33 Thousand | 43 Thousand |
| Investments in PPE | - | - | - | - | -33 Thousand | 43 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 500 Thousand | 500 Thousand | - | 785 Thousand | 1.01 Million | 1.01 Million |
| Debt repayment | -500 Thousand | -500 Thousand | - | -785 Thousand | -1.01 Million | -1.01 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 2000.00 |
| Other Financing Activities | - | - | - | 785 Thousand | 1.01 Million | 1.01 Million |
| Accounts receivables | -64 Thousand | -63 Thousand | 176 Thousand | -62 Thousand | -84 Thousand | -97 Thousand |
| Accounts payables | 67 Thousand | 121 Thousand | -261 Thousand | 274 Thousand | -43 Thousand | -167 Thousand |
| Inventory | 18 Thousand | - | 30 Thousand | -16 Thousand | 57 Thousand | 67 Thousand |
| Other working capital | 66 Thousand | 56 Thousand | 73 Thousand | -196 Thousand | -37 Thousand | 112 Thousand |
| Cash at beginning of period | 517 Thousand | 632 Thousand | 1.51 Million | 1.17 Million | 3.46 Million | 856 Thousand |
| Cash at end of period | 424 Thousand | 517 Thousand | 632 Thousand | 1.51 Million | 1.17 Million | 1.17 Million |
| Capital Expenditure | - | - | - | - | -33 Thousand | 43 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -2000.00 |
| Net cash flow / Change in cash | -93 Thousand | -115 Thousand | -883 Thousand | 345 Thousand | -2.29 Million | 314 Thousand |
| Free Cash Flow | -593 Thousand | -615 Thousand | -883 Thousand | -440 Thousand | -3.31 Million | -701 Thousand |
8427
CGRA3
300036
OHB
ALEX
SVED-B